Literature DB >> 8087868

Improved sensitization of antigen-presenting cells with transferrin-bound peptides: advantages in competition for antigen presentation.

D Mauri1, T Wyss-Coray, C Brander, W J Pichler.   

Abstract

T cells recognize peptides in association with major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells (APC). To sensitize APC for antigen presentation in vitro and in vivo, high concentrations of synthetic peptides can be added from the outside and bind to the MHC molecules, thereby mimicking naturally processed peptides. In this report we investigated whether the transferrin (Tf) molecule could be used as a carrier to introduce antigenic peptides into the antigen presentation pathway of APC. We coupled to Tf various MHC class II DR1 restricted peptides and compared the sensitization of DR1+ APC by the Tf-bound or by the soluble peptide, using peptide-specific T cell clones (TCC). The presentation of the Tf-bound peptides was MHC restricted and could be blocked by the fixation of the APC with glutaraldehyde or by the addition of an excess of Tf. Tf-bound peptides were more efficiently presented than soluble peptides, since smaller concentrations were required to sensitize APC. Moreover, they could compete with a soluble peptide for MHC restricted presentation with a very high efficiency if compared to soluble competing peptides. Tf peptide conjugates could even compete with the presentation of a native antigen like tetanus toxoid. Peptides bound to the transferrin molecule might be useful for immunization strategies, as the relevant bound peptides are efficiently presented to peptide-specific TCC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087868     DOI: 10.1006/cimm.1994.1256

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  Inhibition of T cell responses by transferrin-coupled competitor peptides.

Authors:  Lolita Zaliauskiene; Rebecca L Fazio; Sunghyun Kang; Kerri Sparks; Casey T Weaver; Kurt R Zinn; James F Collawn
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  Involvement of CD80 in the generation of CD4+ cytotoxic T cells.

Authors:  D Mauri; W J Pichler
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

4.  Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.

Authors:  M M Uttenreuther-Fischer; H Feistel; F Wolf; W Jäger
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.